AMISULPRIDE STRAGEN 100 mg/ml, oral solution bottle, 60 ml
Active ingredients: AMISULPRIDE
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 60 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMISULPRIDE STRAGEN 100 mg/mL, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant de 60 ml avec seringue pour administration orale (graduée tous les 0,5 mL).
- Marketing authorisation holder
- STRAGEN-FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Aug 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65315136CIP73020764CIP133400930207642Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMISULPRIDEsolution | 100 mg · 1 mL de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: AMISULPRIDE 100 mg/ml - SOLIAN 100 mg/ml, solution buvable